The Definitive Guide to
Ketamine Troches
Your Complete Ketamine Troche Resource
Comprehensive Guides
Deep-dive troche therapy guides and practical references.
The Complete Guide to Ketamine Troches
Everything you need to know about ketamine troches — from how sublingual administration works to dosing, technique, side effects, and what to expect during at-home treatment.
The Comprehensive Ketamine Troche Safety Guide
Everything you need to know about safely using ketamine troches at home — covering medical screening, contraindications, side effect management, drug interactions, emergency protocols, and long-term safety monitoring.
The Comprehensive Guide to Sublingual Ketamine Therapy
A deep-dive guide to sublingual ketamine troche therapy — covering how sublingual delivery works, treatment protocols, session preparation, integration, long-term management, and what the research says about outcomes.
Interactive Tools
Explore by Category
103 articlesKetamine Troches vs. Nasal Spray: Sublingual vs. Intranasal Delivery
ComparisonKetamine Troches vs. Intramuscular (IM) Injections: A Complete Comparison
ComparisonCompounded vs. Commercial Ketamine Troches: Understanding the Difference
Esketamine vs. Troches: What TRD Patients Should Know
A new clinical review on esketamine for TRD highlights access barriers and patient preferences — here's what it means for ketamine troche therapy.
Esketamine TRD Access Gaps Open Doors for Troches
New clinician data on esketamine for TRD reveals access barriers that make compounded ketamine troches a practical frontline option for many patients.
France Approves IV Ketamine for Suicidal Crisis: What It Means
France has approved IV ketamine for acute suicidal crises. Here's what this global shift means for ketamine troche patients and at-home treatment access in the U.S.
Glutamate Pathways Are Reshaping TRD Treatment
A 2026 review highlights how glutamate-targeting drugs like esketamine and ketamine troches are redefining treatment-resistant depression care.
Glutamate Pathway Treatments Reshape TRD Care
New research highlights glutamate-based treatments for treatment-resistant depression. Here's what it means for ketamine troche patients in 2026.
BXCL501 Enters Phase 2a for Acute Stress and PTSD Prevention
BioXcel's sublingual dexmedetomidine enters a DoD-backed Phase 2a trial for acute stress reactions — what it means for the trauma treatment landscape.